Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma
Michael T. Tetzlaff, Penvadee Pattanaprichakul, Jennifer A. Wargo, et al.
Human Pathology (2015) Vol. 46, Iss. 8, pp. 1101-1110
Open Access | Times Cited: 50

Showing 26-50 of 50 citing articles:

Giemsa is the optimal counterstain for immunohistochemical detection of BRAF V600E mutation status in pigmented melanomas
Sanjita Ravishankar, Priyadharsini Nagarajan, Jonathan L. Curry, et al.
Journal of Cutaneous Pathology (2016) Vol. 43, Iss. 8, pp. 722-724
Closed Access | Times Cited: 9
Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma
Alan Siroy, Phyu P. Aung, Carlos A. Torres‐Cabala, et al.
Human Pathology (2016) Vol. 59, pp. 48-54
Closed Access | Times Cited: 8
Immunohistochemistry as an accurate tool for the assessment of BRAF V600E and TP53 mutations in primary and metastatic melanoma
Ștefan Rusu, Camille Verocq, Anne Trepant, et al.
Molecular and Clinical Oncology (2021) Vol. 15, Iss. 6
Open Access | Times Cited: 8
BRAF testing modalities in histiocytic disorders: Comparative analysis and proposed testing algorithm
Aldo A. Acosta‐Medina, Jithma P. Abeykoon, Ronald S. Go, et al.
American Journal of Clinical Pathology (2023) Vol. 160, Iss. 5, pp. 483-489
Closed Access | Times Cited: 3
Lung Metastases from Esophageal Granular Cell Tumor: An Undoubted Criterion for Malignancy
Isidro Machado, Julia Cruz, Estanislao Arana, et al.
Journal of Thoracic Oncology (2017) Vol. 12, Iss. 8, pp. 1320-1322
Open Access | Times Cited: 7
Result Analysis of BRAF V600E Gene Mutation Using Molecular and Immunohistochemistry Detection in Acral Malignant Melanoma
Hermin Aminah Usman, Bethy Hernowo, Maringan Diapari Lumbantobing, et al.
Asian Pacific Journal of Cancer Care (2018) Vol. 3, Iss. 3, pp. 43-43
Open Access | Times Cited: 6
Molekulare und immunhistochemische Diagnostik beim Melanom
Bastian Schilling, Klaus Griewank
Der Hautarzt (2016) Vol. 67, Iss. 7, pp. 511-518
Closed Access | Times Cited: 4
BRAF V600E immunohistochemistry as a useful tool in the diagnosis of melanomas with ambiguous morphologies and immunophenotypes
Aimi T. Rothrock, Nadia Hameed, Woo Cheal Cho, et al.
Journal of Cutaneous Pathology (2022) Vol. 50, Iss. 3, pp. 223-229
Closed Access | Times Cited: 4
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting
Richard A. Scolyer, Victoria Atkinson, David Gyorki, et al.
Pathology (2021) Vol. 54, Iss. 1, pp. 6-19
Closed Access | Times Cited: 5
Evaluation of HSP-27, BAP1, BRAF V600E, CCR7, and PD-L1 expression in uveal melanoma on enucleated eyes and metastatic liver tumors
Abdullah Ağın, Hayyam Kıratlı, Servet Güreşçi, et al.
The International Journal of Biological Markers (2022) Vol. 37, Iss. 2, pp. 200-209
Open Access | Times Cited: 3
VE1 Immunohistochemistry Fails to Detect Most of the Non-BRAFV600E Mutations in Melanoma
Arnaud Uguen, Marie Uguen
Applied immunohistochemistry & molecular morphology (2016) Vol. 24, Iss. 10, pp. e98-e99
Closed Access | Times Cited: 2
BRAFV600E Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics
X. Soria, F Vilardell, Óscar Maiques, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5073-5073
Open Access | Times Cited: 3
Cutaneous metastases
George Jour, Rami N. Al‐Rohil
Diagnostic histopathology (2019) Vol. 25, Iss. 3, pp. 87-95
Closed Access | Times Cited: 2
Molecular Biology of Iris
Kambiz Thomas Moazed
Deleted Journal (2020), pp. 105-160
Closed Access | Times Cited: 2
Biomarker Analysis of Gene-Mutated Protein Products by Immunohistochemistry in Melanoma
Carlos A. Torres‐Cabala, Michael T. Tetzlaff, Jonathan L. Curry
Springer eBooks (2016), pp. 181-191
Closed Access | Times Cited: 1
BRAF Mutation Analysis in Primary Acral Melanoma of 41 Cases from South of Iran
Fatemeh Sari Aslani, Akbar Safaee, Mojgan Akbarzadeh‐Jahromi, et al.
Iranian journal of pathology (2021) Vol. 16, Iss. 4, pp. 370-375
Open Access | Times Cited: 2
A validation study for the use VE1 immunohistochemical staining in screening for BRAF mutation in cutaneous malignant melanoma
Weiming Zhang, Guoxin Song, Xue Han, et al.
Biomedical Research-tokyo (2017) Vol. 28, Iss. 11, pp. 4886-4890
Closed Access | Times Cited: 1
Skin
Tammie Ferringer
Springer eBooks (2022), pp. 921-954
Closed Access | Times Cited: 1
Immunohistochemical Detection of BRAFV600E in Cutaneous Melanocytic Neoplasms in a Cohort of Egyptian Population
Nada M. Yakout, Dina Abdallah, Doaa A. Abdelmonsif, et al.
Asian Pacific Journal of Cancer Care (2022) Vol. 7, Iss. 4, pp. 747-751
Open Access | Times Cited: 1
BRAF Mutation Analysis in Primary Acral Melanoma of 41 Cases from South of Iran.
Fatemeh Sari Aslani, Akbar Safaee, Mojgan Akbarzadeh‐Jahromi, et al.
PubMed (2021) Vol. 16, Iss. 4, pp. 370-375
Closed Access | Times Cited: 1
Immunohistology of Melanocytic Lesions
Jonathan L. Curry, Michael T. Tetzlaff, Priyadharsini Nagarajan, et al.
Springer eBooks (2016), pp. 311-334
Closed Access
Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry
Priyadharsini Nagarajan, M.T. Tetzlaff, Johnathan L. Curry, et al.
Actas Dermo-Sifiliográficas (2016) Vol. 108, Iss. 1, pp. 17-30
Open Access
Rapid BRAF mutation detection in melanoma patients by immunohistochemistry
László Fülöp, Katalin Götzer, Erzsébet Csernák, et al.
Journal of Universal Science Online (2017) Vol. 4, Iss. 1, pp. 1-5
Open Access
Genomic Applications in Melanoma
Carlos Prieto‐Granada, John Van Arnam, Kabeer Shah, et al.
Springer eBooks (2018), pp. 509-540
Closed Access
Skin
Carlos A. Torres‐Cabala, Michael T. Tetzlaff, Priyadharsini Nagarajan, et al.
Springer eBooks (2020), pp. 3-227
Closed Access
Previous Page - Page 2

Scroll to top